Seven-Year Experience and Follow-Up with St. Jude Medical® Prostheses

  • L. C. D’Alessandro
  • A. Pucci
  • P. Mamone
  • R. Cini


At the Division of Cardiac Surgery of St. Camillo Hospital, 1411 patients were operated on for valve replacement with ST. JUDE MEDICAL® prostheses from November 1978 through June 30, 1986. Six hundred eighty patients had mitral valve replacement (MVR), 468 had aortic valve replacement (A VR), 5 had tricuspid valve replacement (TVR), 246 had MVR + AVR, 8 had MVR + TVR, 1 had AVR + TVR, 3 had MVR + AVR + TVR, and 1 had MVR + AVR as well as ascending aorta replacement with a ST. JUDE MEDICAL aortic valved graft. The total number of implanted prostheses was 1672. Associated procedures were: left atrium thrombectomy 98, tricuspid valve repair 92, coronary artery bypass grafting 52, subaortic membrane repair 19, and atrial septal defect closure 16. The operative mortality rate was 9.3% for MVR, 5.8% for AVR, 40% for TVR, 6.8% for MVR + AVR, 14% for MVR + TVR, 66.6% for MVR + AVR + TVR, and 0% for AVR + TVR. The 7-year actuarial survival rate was 78% for MVR, 86% for AVR, and 80% for MVR + AVR. At 7 years, the actuarial rate of freedom from thromboembolism was 82% for the complete series, and the actuarial rate of freedom from major events (prosthesis failure and prosthesis thrombosis) was 92%. Seven-year actuarial survival in patients with concomitant coronary artery bypass grafting was similar to that for patients without coronary artery disease. Clinical improvement was observed in 97% of patients.


Valve Replacement Aortic Valve Replacement Mitral Valve Replacement Jude Medical Valve Thrombosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Emery RW, Mettler E, Nicoloff DM. A new cardiac prosthesis: The St. Jude Medical cardiac valve: In vivo results. Circulation 1979; 60:48.PubMedGoogle Scholar
  2. 2.
    Duncan JM, Cooley DA, Livesay JJ, Ott DA, Reul GJ, Walker WE, Frazier OH. The St. Jude Medical valve: Early clinical results in 253 patients. Texas Heart Inst J 1983; 10:11.Google Scholar
  3. 3.
    Horstkotte D, Haerten K, Herzer JA, Seipel L, Bircks W, Loogen F. Preliminary results in mitral valve replacement with the St. Jude Medical prosthesis: Comparison with the Björk-Shiley valve. Circulation 1981; 64(Suppl II):II-203.Google Scholar
  4. 4.
    Baudet EM, Oca CC, Roques XF, Laborde MN, Hafez AS, Collot MA, Ghidoni IM. A 5½ year experience with the St. Jude Medical cardiac prosthesis. Early and late results of 737 valve replacements in 671 patients. J Thorac Cardiovasc Surg 1985; 90:137.PubMedGoogle Scholar
  5. 5.
    Duncan JM, Cooley DA, Reul GJ, Ott DA, Hallman GL, Frazier OH, Livesay JJ, Walker WE, Adams PR. Durability and low thrombogenicity of the St. Jude Medical valve at 5-year follow-up. Ann Thorac Surg 1986; 42:500.PubMedCrossRefGoogle Scholar
  6. 6.
    Grunkemeier GL, Starr A. Actuarial analysis of surgical results: Rationale and method. Ann Thorac Surg 1977; 24:404.PubMedCrossRefGoogle Scholar
  7. 7.
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 1958; 53:457–481.CrossRefGoogle Scholar
  8. 8.
    Wortham DC, Tri TB, Bowen TE. Hemodynamic evaluation of the St. Jude Medical valve in the small aortic anulus. J Thorac Cardiovasc Surg 1981; 81:615.PubMedGoogle Scholar
  9. 9.
    Konno S, Imai Y, Iida Y, Nakajima M, Tatsuno K. A new method for prosthetic valve replacement in congenital aortic stenosis associated with hypoplasia of the aortic valve ring. J Thorac Cardiovasc Surg 1975; 70:909–917.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • L. C. D’Alessandro
  • A. Pucci
  • P. Mamone
  • R. Cini

There are no affiliations available

Personalised recommendations